MedGenome expands in East India with stake in GenX Diagnostics

The partnership aims to enhance genetic and molecular testing in Odisha, leveraging advanced technology to improve healthcare outcomes

0
140
New Delhi: MedGenome has announced the acquisition of a stake in GenX Diagnostics, a prominent diagnostic lab chain in Odisha.
This strategic move is set to bolster MedGenome’s presence in East India and expand its reach in providing advanced genomic and diagnostic solutions.
GenX Diagnostics, founded in 2017, has made significant strides in the diagnostic sector in Odisha, operating seven diagnostic centers and 60 collection centers throughout the state. The flagship laboratory in Saheed Nagar, Bhubaneshwar, is accredited by both NABL and NABH. The company, led by healthcare veterans Dr. Biswajit Mohanty and Dr. Bikash Agarwal, with more than 2-3 decades of clinical experience, boasts a strong network of clinicians and has been recognized for its commitment to healthcare excellence, winning prestigious awards such as the Best Diagnostic Center by Times Health Icons in 2023 and 2024 and the Best Productivity Excellence Award by the Odisha State Productivity Council in 2024.
With MedGenome’s state-of-the-art technology and GenX Diagnostics’ established regional leadership, this partnership is poised to provide significant growth opportunities. The integration aims to enhance the penetration of genetic and molecular testing in the region, empowering clinicians in Odisha with actionable insights from genetic data and enabling more targeted treatments for patients.
Dr. Vedam Ramprasad, CEO of MedGenome, commented on the acquisition, stating, “With the acquisition of a stake in GenX Diagnostics, MedGenome will expand its market presence and product portfolio of over 1300 tests in order to cater to a wider population base more effectively. GenX Diagnostics sits perfectly with our vision and mission to leverage genomics to address the unmet healthcare need in the country. Their mission to provide quality, reliable, and innovative diagnostic solutions align with our focus on improving access to broader omics solutions. This acquisition further aims to expand our network in Tier 2 and Tier 3 cities in India by driving deeper penetration, new market development, and bringing new tests to the market. With a focus on positioning Indian genomics globally, we develop solutions that cater to diverse markets worldwide.”
Dr. Biswajit Mohanty of GenX Diagnostics, Bhubaneswar expressed, “We are thrilled to announce the expansion of our advanced healthcare solutions in Odisha through our partnership with MedGenome. This strategic collaboration aims to enhance healthcare services in the region, providing comprehensive and cutting-edge diagnostic solutions. We are committed to bringing sophisticated and advanced healthcare solutions to the people of Odisha. By combining our extensive product portfolio with MedGenome’s omics solutions, we will empower clinicians and consumers in Eastern India with the best diagnostic tools available.”